Featured
-
This Just In: Avandia stays on the market
In a 22-1 vote, a panel advising the FDA on the future of popular diabetes drug Avandia chose to keep the drug on the market.
-
Live from the Avandia Review: 7:30 a.m.
Judging by the hoopla in this Holiday Inn in Gaithersburg, Md., people have really been paying attention to all the recent controversy about Avandia.
-
Avandia Review: Tell Us Something We Don't Know!
An introduction to the growing problem of type 2 diabetes from the FDA panel's Avandia review.
